Many life science BD teams use LinkedIn Sales Navigator to find people, map relationships, manage account lists, and prioritize opportunities. Arcova does not own prioritization as a category: Sales Navigator's Account Hub explicitly supports it. Arcova adds a different evidence set, applying a customer-specific life science ICP and company-level readiness model to public trial, regulatory, funding, hiring, and conference activity.
What does LinkedIn Sales Navigator actually do?
Sales Navigator is LinkedIn's sales product, positioned as an AI-powered B2B sales tool for finding buyers and growing pipeline across LinkedIn's network of more than a billion members. Its core mechanics, as LinkedIn's official plan comparison presents them: lead and account search with more than 50 filters, saved lists with alerts on job changes and account activity, InMail messaging for reaching people outside your network, and TeamLink for surfacing warm introduction paths through colleagues. Recent versions add AI features, such as account and lead summaries and message drafting help, and the higher tiers add buyer intent signals based on engagement with your company's LinkedIn presence plus CRM integrations, with full CRM sync reserved for the top, quote-based tier. As of July 2026 it is sold as Core, Advanced, and Advanced Plus.
Sales Navigator also has genuine account-level prioritization. LinkedIn's official Account Hub documentation describes buyer intent, relationship intelligence, account alerts, and, on eligible plans, CRM opportunity data. It lists funding and acquisition, growth, and risk alerts as well as buyer-intent sorting. Its center of gravity remains LinkedIn, website engagement, relationship, and CRM evidence rather than the detailed life science public record.
What does Arcova add on top of Sales Navigator?
Arcova supplies a life science-specific account view alongside that existing prioritization. It scores each account on your list for ICP fit using attributes such as therapeutic area, modality, and development stage, and watches the life science public record, trial registrations and phase transitions, FDA decisions and designations, funding rounds, conference activity, and hiring, for the readiness signals that may justify timely research or outreach. The output is a ranked list with reasons attached: which accounts to work now, and what changed. The rep then takes that answer into Sales Navigator, where finding and reaching the right person is exactly the job it does best.
| Sales Navigator | Arcova | |
|---|---|---|
| What it is | People-finding and outreach layer on LinkedIn's network | Life science account fit and readiness layer |
| Core question | Which accounts and people deserve focus based on intent and relationships? | Which life science accounts fit your ICP, and what changed publicly? |
| Where its signals come from | LinkedIn, website intent, relationships, alerts, and eligible CRM data | The life science public record: trials, FDA, funding, conferences |
| Industry scope | Every industry | Life science only, scored against your ICP |
| Outreach | InMail and AI-assisted messaging built in | Works with the outreach stack you already run |
| Pricing | Published per-seat tiers; top tier quote-based (as of July 2026) | Free to start |
When is Sales Navigator alone enough?
Genuinely often. If your team sells into a short, stable, well-understood account list, where the open question is reaching the right people rather than choosing accounts, Sales Navigator covers the whole distance. The same is true when selling is relationship-led and TeamLink's warm-path surfacing is the real engine of the motion, or for an individual seller whose territory is small enough to hold in their head. Prioritization tooling earns its keep when the account universe outgrows what a team can judge account by account; below that line, adding a scoring layer solves a problem you do not have yet.
Related comparisons
See how Arcova compares to ZoomInfo, Apollo, and your outreach tool as well.